Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ENO1 | P06733 | 2/20 | 0.40 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | POLA1 | P09884 | 1/20 | 0.32 |
| ▸ | POLG | P54098 | 1/20 | 0.32 |
| ▸ | FAP | Q12884 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25866618 | 0.85 | ALDH1A1 (0.53) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL28720185 | 0.80 | BTN3A1 (0.53) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL3437081 | 0.80 | BTN3A1 (0.53) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL10378801 | 0.80 | BTN3A1 (0.49) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL2461589 | 0.79 | ALDH1A1 (0.51) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL2459326 | 0.79 | ALDH1A1 (0.48) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL18309164 | 0.79 | BTN3A1 (0.47) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL10128755 | 0.79 | BTN3A1 (0.47) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL10378847 | 0.79 | BTN3A1 (0.51) | BTN3A1ALDH1A1ENO1FNTAFNTB | |
| SCHEMBL10378800 | 0.78 | BTN3A1 (0.50) | BTN3A1ALDH1A1ENO1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164680-A1 | 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | RECLUDIX PHARMA, INC. (US) | 2023-08-31 | — | — | WO | disclosed |